Education
About Us
Working with TipRanks
Follow Us
Knight Therapeutics (TSE:GUD)
TSX:GUD
GUD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$5.09 - C$6.45
Previous CloseN/A
Volume40.10K
Average Volume (3M)85.26K
Market Cap
$612.03M
Enterprise ValueC$441.39M
Total Cash (Recent Filing)C$244.78M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)140.2
Beta0.21
Next Earnings
May 08, 2025EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding99,517,670
10 Day Avg. Volume85,820
30 Day Avg. Volume85,261
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.79
Price to Cash Flow (P/CF)31.20
P/FCF Ratio48.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$7.91Price Target Upside28.19% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
---
Bulls Say, Bears Say
Bulls Say
ContractsRevenues are expected to be higher due to Knight re-signing a $22.4M contract with the Brazilian Ministry of Health.
EarningsKnight reported 4Q-2024 results that beat estimates.
Bears Say
ProfitabilityEBITDA margin was lower despite the revenue growth.
---
Options Prices
Currently, No data available
---
Ownership Overview
35.20% Insiders
2.21%
Mutual Funds
0.09% Other Institutional Investors
61.93% Public Companies and
Individual Investors
GUD FAQ
What was Knight Therapeutics’s price range in the past 12 months?
Knight Therapeutics lowest stock price was C$5.08 and its highest was C$6.45 in the past 12 months.
What is Knight Therapeutics’s market cap?
Knight Therapeutics’s market cap is $612.03M.
When is Knight Therapeutics’s upcoming earnings report date?
Knight Therapeutics’s upcoming earnings report date is May 08, 2025 which is in 35 days.
How were Knight Therapeutics’s earnings last quarter?
Knight Therapeutics released its earnings results on Mar 20, 2025. The company reported C$0.11 earnings per share for the quarter, beating the consensus estimate of C$0.018 by C$0.092.
Is Knight Therapeutics overvalued?
According to Wall Street analysts Knight Therapeutics’s price is currently Undervalued.
Does Knight Therapeutics pay dividends?
Knight Therapeutics does not currently pay dividends.
What is Knight Therapeutics’s EPS estimate?
Knight Therapeutics’s EPS estimate is <0.01.
How many shares outstanding does Knight Therapeutics have?
Knight Therapeutics has 99,517,670 shares outstanding.
What happened to Knight Therapeutics’s price movement after its last earnings report?
Knight Therapeutics reported an EPS of C$0.11 in its last earnings report, beating expectations of C$0.018. Following the earnings report the stock price went up 0.32%.
Which hedge fund is a major shareholder of Knight Therapeutics?
Currently, no hedge funds are holding shares in TSE:GUD
---
Company Description
Knight Therapeutics
Knight Therapeutics Inc. (GUD) is a Canadian-based specialty pharmaceutical company focused on acquiring, in-licensing, and commercializing innovative pharmaceutical products for the Canadian and select international markets. The company operates in the healthcare sector, offering a portfolio of prescription and over-the-counter medicines that address unmet medical needs.
---
GUD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Knight Therapeutics reported record revenues and significant pipeline expansion but faced challenges with declining gross margins, decreased adjusted EBITDA, and competition from generic products. The acquisition of Paladin and new contracts in Brazil are positive, but these are offset by currency and hyperinflation challenges.Read More>---
GUD Stock 12 Month Forecast
Average Price Target
C$7.91
▲(28.19% Upside)
Technical Analysis
Best Analysts Covering GUD
1 Year
1 Year Success Rate
10/20 ratings generated profit
1 Year Average Return
-1.63%
reiterated a buy rating 15 days ago
Copying Douglas Miehm's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.63% per trade.
---